The rise of artificial intelligence has brought both opportunities and challenges to the workplace. However, a growing trend of employees using free or unauthorized AI tools poses significant risks, from security breaches to...more
5/15/2025
/ Artificial Intelligence ,
Cybersecurity ,
Data Privacy ,
Data Security ,
Employee Training ,
Employees ,
Employer Liability Issues ,
Employment Policies ,
Intellectual Property Protection ,
National Security ,
Popular ,
Risk Factors ,
Risk Management ,
Technology ,
Trade Secrets
This week, we take a closer look at two precedential cases concerning pharmaceutical patent protections as applied to drugs in development.
In Incyte Corp. v. Sun Pharm., Judge Hughes entered a dissent pushing back on the...more
5/13/2025
/ Appeals ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Hatch-Waxman ,
Injunctive Relief ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Remand ,
USPTO
State and local governments: Do your websites and mobile apps meet accessibility standards?
The compliance dates for DOJ’s digital accessibility requirements are coming soon!
Title II of the Americans with Disabilities Act...more
Recentive Analytics, Inc., v. Fox Corp., Appeal No. 2023-2437 (Fed. Cir. Apr. 18, 2025)
In our Case of the Week, the Federal Circuit addressed a question of first impression concerning whether developments in machine...more
4/22/2025
/ Algorithms ,
Alice/Mayo ,
Appeals ,
Artificial Intelligence ,
Innovative Technology ,
Intellectual Property Litigation ,
Inter Partes Review (IPR) Proceeding ,
Machine Learning ,
Patent Invalidity ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Prior Art ,
Section 101
Actavis Labs. FL, Inc. v. United States, Appeal No. 2023-1320 (Fed. Cir. Mar. 21, 2025)
Our Case of the Week, in the words of its author, Circuit Judge Stark, “is not actually a patent case. It is, instead, a tax case.” In...more
3/25/2025
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Claim Construction ,
Court of Federal Claims ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Hatch-Waxman ,
Inter Partes Review (IPR) Proceeding ,
International Trade Commission (ITC) ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
USPTO
In re: Xencor, Inc., Appeal No. 2024-1870 (Fed. Cir. Mar. 13, 2025)
Our case of the week is an appeal from a decision of the Appeals Review Panel of the Patent Trial and Appeal Board, concerning Xencor’s patent application...more
3/18/2025
/ Appeals ,
Claim Construction ,
Federal Court Litigation ,
Intellectual Property Protection ,
Life Sciences ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Reissue Patents ,
Written Descriptions
Apple Inc. v. Gesture Technology Partners, LLC, Appeal Nos. 2023-1475, -1533 (Fed. Cir. Mar. 4, 2025)
Our Case of the Week is a high-stakes appeal from an inter partes review concerning a patent titled “Camera Based...more
3/11/2025
/ Appeals ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Remand ,
Technology ,
USPTO ,
Vacated
CloudofChange, LLC v. NCR Corp., Appeal No. 2023-1111 (Fed. Cir. Dec. 18, 2024)
In our Case of the Week, the Federal Circuit addressed the question of divided infringement in the context of system claims. In its...more
12/24/2024
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Claim Construction ,
Food and Drug Administration (FDA) ,
Hatch-Waxman ,
Inter Partes Review (IPR) Proceeding ,
Motivation to Combine ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Remand ,
Reversal ,
Technology ,
Vacated
On December 16, the U.S. Department of Defense’s Cybersecurity Maturity Model Certification Program (CMMC) final rule (the “CMMC Program Rule”) will become effective, to codify the CMMC requirements and assessment processes....more
11/19/2024
/ Controlled Unclassified Information (CUI) ,
Cybersecurity ,
Cybersecurity Maturity Model Certification (CMMC) ,
Department of Defense (DOD) ,
Department of Justice (DOJ) ,
False Claims Act (FCA) ,
Federal Contractors ,
Final Rules ,
New Rules ,
NIST ,
Regulatory Agenda ,
Regulatory Requirements ,
Third Party Assessment Organization (3PAO)